• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视佛蒙特州初级保健医生的前列腺癌筛查实践。

Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.

机构信息

Larner College of Medicine at the University of Vermont, Burlington, VT, 05401, USA.

Division of Urology, Department of Surgery, Larner College of Medicine at the University of Vermont, Burlington, VT, USA.

出版信息

J Community Health. 2018 Feb;43(1):33-37. doi: 10.1007/s10900-017-0384-x.

DOI:10.1007/s10900-017-0384-x
PMID:28620736
Abstract

The objective of this study was to assess the prostate cancer screening practices of Vermont primary care physicians and compare them with a prior study in 2001. An electronic survey was created and emailed to all currently practicing primary care physicians in Vermont. Data was stratified by practice length, practice location, university affiliation, and internal medicine versus family practice. Surveys were received from 123 (27.2%) primary care physicians. 27.7% of physicians in practice <10 years recommended prostate specific antigen (PSA) testing, compared with 55.9% of those practicing ≥10 years (p = 0.006). Of those who modified their recommendations in the past 5 years, 96.1% reported that the United States Preventive Services Task Force (USPSTF) 2012 statement influenced them. Respondents who continued to use PSA testing were less likely to stop screening after age 80 compared with those surveyed in 2001 (51% in 2014 vs. 74% in 2001; p <0.001). Primary care physicians in practice for 10 or more years were more likely to recommend PSA-based screening than those in practice for less time. The USPSTF statement discouraging PSA-based screening for prostate cancer has had significant penetrance among Vermont primary care physicians.

摘要

本研究旨在评估佛蒙特州初级保健医生的前列腺癌筛查实践,并将其与 2001 年的一项先前研究进行比较。创建了一个电子调查并通过电子邮件发送给佛蒙特州所有现任初级保健医生。数据按执业年限、执业地点、大学附属关系以及内科与家庭实践进行分层。共收到 123 名(27.2%)初级保健医生的调查回复。与从业 10 年以上的医生(55.9%)相比,从业不足 10 年的医生(27.7%)推荐前列腺特异性抗原(PSA)检测的比例更高(p=0.006)。在过去 5 年内修改其建议的医生中,96.1%报告说美国预防服务工作组(USPSTF)2012 年的声明影响了他们。与 2001 年调查的医生相比,那些继续使用 PSA 检测的医生在 80 岁以后停止筛查的可能性更小(2014 年为 51%,2001 年为 74%;p<0.001)。从业 10 年或以上的初级保健医生比从业时间较短的医生更有可能推荐基于 PSA 的筛查。USPSTF 关于不鼓励基于 PSA 的前列腺癌筛查的声明在佛蒙特州初级保健医生中具有显著影响力。

相似文献

1
Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.重新审视佛蒙特州初级保健医生的前列腺癌筛查实践。
J Community Health. 2018 Feb;43(1):33-37. doi: 10.1007/s10900-017-0384-x.
2
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践:2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
3
[Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].[使用前列腺特异性抗原进行前列腺癌筛查:普通医生和检验医生的观点]
Semergen. 2018 Sep;44(6):409-419. doi: 10.1016/j.semerg.2018.02.001. Epub 2018 Mar 21.
4
Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.初级保健医生对前列腺特异性抗原证据不确定性、筛查效果和检测使用的看法。
J Natl Med Assoc. 2018 Oct;110(5):491-500. doi: 10.1016/j.jnma.2017.12.007. Epub 2018 May 7.
5
Prostate cancer screening practices amongst physicians in the North Simcoe Muskoka Local Health Integration Network.北锡姆科-马斯科卡地方卫生整合网络内医生的前列腺癌筛查实践
Can J Urol. 2017 Apr;24(2):8734-8739.
6
Prostate-specific antigen screening: An update of physician beliefs and practices.前列腺特异性抗原筛查:医生观念和实践的更新。
Prev Med. 2017 Oct;103:66-69. doi: 10.1016/j.ypmed.2017.08.004. Epub 2017 Aug 6.
7
Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.基层医疗视角以及嵌入电子健康记录的多学科机构前列腺癌筛查算法的实施
Urol Oncol. 2018 Nov;36(11):502.e1-502.e6. doi: 10.1016/j.urolonc.2018.07.016. Epub 2018 Aug 28.
8
Seniority of primary care physicians is associated with a decrease in PSA ordering habits in the years surrounding the United States Preventative Services Task Force recommendation against PSA screening.在美国预防服务工作组发布反对前列腺特异性抗原(PSA)筛查的建议前后几年,初级保健医生的资历与PSA检测开单习惯的减少有关。
Urol Oncol. 2018 Nov;36(11):500.e21-500.e27. doi: 10.1016/j.urolonc.2018.07.011. Epub 2018 Sep 18.
9
Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.基层医疗中医生对前列腺特异性抗原检测及过度诊断的处理方式:一项定性研究。
BMJ Open. 2015 Mar 17;5(3):e006367. doi: 10.1136/bmjopen-2014-006367.
10
Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.2012年美国预防服务工作组(USPSTF)发布建议后,泌尿科医生和初级保健医生在前列腺特异性抗原检测方面的差异。
JAMA Intern Med. 2016 Apr;176(4):546-7. doi: 10.1001/jamainternmed.2015.7901.

引用本文的文献

1
Health Professionals' Perceptions about Prostate Cancer-A Focus Group Study.健康专业人员对前列腺癌的看法——一项焦点小组研究
Cancers (Basel). 2024 Aug 29;16(17):3005. doi: 10.3390/cancers16173005.

本文引用的文献

1
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.2012 年美国预防服务工作组建议不鼓励基于前列腺特异性抗原的前列腺癌筛查后,全国前列腺癌筛查率。
J Clin Oncol. 2015 Aug 1;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. Epub 2015 Jun 8.
2
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.前列腺癌筛查与死亡率:欧洲前列腺癌筛查随机研究(ERSPC)13年随访结果
Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
3
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
前列腺癌筛查:美国医师学院临床指南委员会的指导声明。
Ann Intern Med. 2013 May 21;158(10):761-769. doi: 10.7326/0003-4819-158-10-201305210-00633.
4
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
5
Mortality results from a randomized prostate-cancer screening trial.一项前列腺癌随机筛查试验的死亡率结果。
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18.
6
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.前列腺特异性抗原水平≤4.0纳克/毫升的男性中前列腺癌的患病率。
N Engl J Med. 2004 May 27;350(22):2239-46. doi: 10.1056/NEJMoa031918.
7
Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.临床实践。前列腺特异性抗原检测用于前列腺癌的早期诊断。
N Engl J Med. 2001 May 3;344(18):1373-7. doi: 10.1056/NEJM200105033441806.